Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain

Post time 6 day(s) ago

journal：Journal of Medicinal Chemistry

Authors：Jinshan Nan; Jingming Liu; Guifeng Lin; Shanshan Zhang; Anjie Xia; Pei Zhou; Yangli Zhou; Jiahao Zhang; Jinlong Zhao; Shiyu Zhang; Chong Huang; Yifei Wang; Qian Hu; Junxian Chen; Mingli Xiang; Xin Yang; Shengyong Yang

Published date：2023-3-9

DOI：10.1021/acs.jmedchem.2c01943

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01943

Article link：https://doi.org/10.1021/acs.jmedchem.2c01943

Article Source：American Chemical Society (ACS)。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[ACS] Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain